Roche has acquired Therapeutic Human Polyclonals, a private company based in Germany and Mountain View, Ca. that focuses on antibody research, for $56.5 million.

See the statement here.

Roche plans to integrate THP into the Roche Pharma Center of Excellence for Protein Research in Penzberg, Germany.